Exhibit 99.1

PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES ITS SECOND

QUARTER FINANCIAL RESULTS

Pompano Beach, Florida, October 21, 2013 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended September 30, 2013.  Net sales for the quarter ended September 30, 2013 were $60.5 million, compared to $58.1 million for the quarter ended September 30, 2012, an increase of 4.0%.  Net sales for the six months ended September 30, 2013 were $134.7 million, compared to $127.1 million for the quarter ended September 30, 2012, an increase of 6.0%.  Net income was $4.2 million, or $0.21 diluted per share, for the quarter ended September 30, 2013, compared to net income of $4.0 million, or $0.20 diluted per share, for the quarter ended September 30, 2012, a 3.0% increase to EPS.  Net income was $8.9 million, or $0.44 diluted per share, for the six months ended September 30, 2013, compared to net income of $8.0 million, or $0.40 diluted per share, for the six months ended September 30, 2012, a 12.2% increase to EPS.  Reorder sales increased by 5.3%, from $46.4 million to $48.9 million for the quarters ended September 30, 2012 and 2013, respectively.  Additionally, the Company’s online sales increased by 7.3% to $47.9 million for the quarter ended September 30, 2013, compared to $44.6 million for the same quarter the prior year, with approximately 79% of all orders being generated from its website during the quarter compared to 77% for the same quarter the prior year.  

Menderes Akdag, CEO and President, commented: “We are pleased with the strong reorder sales for the quarter.  Our sales increase for the quarter was also highlighted by an increased average order size - $73 for the quarter ended September 30, 2013 compared to $72 for the same quarter in the prior year.  For the quarter ended September 30, 2013 our operating expenses decreased by 140 basis points, mainly due to a reduction in advertising expenses.  Cash flow from operations increased by 55%, from $15.7 million to $24.4 million for the quarters ended September 30, 2012 and 2013, respectively.  For the remainder of Fiscal 2014 we are focusing on improving our gross profit margins and continuing to expand our product offerings.”

This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter’s financial results.  To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025.  Callers will be required to supply PETMEDS as the passcode.  For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on October 21, 2013 until November 4, 2013 at 11:59 P.M.  To access the replay, call (800) 454-0163 (toll free) or (203) 369-3803, and enter passcode 5500.

Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan.  Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2013.  The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.

###

Exhibit 99.1 Page 1 of 4

September 30,

March 31,

2013

2013

(Unaudited)

ASSETS

Current assets:

Cash and cash equivalents

$

35,913

$

18,155

Short term investments - available for sale

15,486

15,490

Accounts receivable, less allowance for doubtful accounts of $5 and $5, respectively

1,384

1,439

Inventories - finished goods

17,341

31,601

Prepaid expenses and other current assets

3,616

2,520

Deferred tax assets

771

982

Prepaid income taxes

779

-

Total current assets

75,290

70,187

Property and equipment, net

1,685

2,132

Intangible asset

860

860

Total assets

$

77,835

$

73,179

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:

Accounts payable

$

8,319

$

6,454

Accrued expenses and other current liabilities

2,208

2,381

Income taxes payable

-

162

Total current liabilities

10,527

8,997

Deferred tax liabilities

150

168

Total liabilities

10,677

9,165

Commitments and contingencies

Shareholders' equity:

Preferred stock, $.001 par value, 5,000 shares authorized;3 convertible shares issued and outstanding with a liquidation preference of $4 per share

9

9

Common stock, $.001 par value, 40,000 shares authorized; 20,190 and 20,109 shares issued and outstanding, respectively

20

20

Additional paid-in capital

732

-

Retained earnings

66,445

63,987

Accumulated other comprehensive loss

(48

)

(2

)

Total shareholders' equity

67,158

64,014

Total liabilities and shareholders' equity

$

77,835

$

73,179

Three Months Ended

Six Months Ended

September 30,

September 30,

2013

2012

2013

2012

Sales

$

60,479

$

58,145

$

134,673

$

127,100

Cost of sales

41,227

38,775

91,408

85,426

Gross profit

19,252

19,370

43,265

41,674

Operating expenses:

General and administrative

5,505

5,371

11,378

11,293

Advertising

6,985

7,424

17,380

17,274

Depreciation

230

249

478

577

Total operating expenses

12,720

13,044

29,236

29,144

Income from operations

6,532

6,326

14,029

12,530

Other income:

Interest income, net

48

64

95

123

Other, net

1

-

(1

)

-

Total other income

49

64

94

123

Income before provision for income taxes

6,581

6,390

14,123

12,653

Provision for income taxes

2,431

2,356

5,218

4,667

Net income

$

4,150

$

4,034

$

8,905

$

7,986

Net change in unrealized gain (loss) on short term investments

-

16

(46

)

25

Comprehensive income

$

4,150

$

4,050

$

8,859

$

8,011

Net income per common share:

Basic

$

0.21

$

0.20

$

0.45

$

0.40

Diluted

$

0.21

$

0.20

$

0.44

$

0.40

Weighted average number of common shares outstanding:

Basic

19,902

19,962

19,875

20,040

Diluted

20,044

20,062

20,024

20,154

Cash dividends declared per common share

$

0.17

$

0.15

$

0.32

$

0.30

Six Months Ended

September 30,

2013

2012

Cash flows from operating activities:

Net income

$

8,905

$

7,986

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation

478

577

Share based compensation

732

1,039

Deferred income taxes

193

113

Bad debt expense

49

27

(Increase) decrease in operating assets and increase (decrease) in liabilities:

Accounts receivable

6

(343

)

Inventories - finished goods

14,260

6,627

Prepaid income taxes

(779

)

(150

)

Prepaid expenses and other current assets

(1,096

)

194

Accounts payable

1,865

337

Income taxes payable

(162

)

-

Accrued expenses and other current liabilities

(93

)

(673

)

Net cash provided by operating activities

24,358

15,734

Cash flows from investing activities:

Net change in investments

(41

)

(5,053

)

Purchases of property and equipment

(31

)

(291

)

Net cash used in investing activities

(72

)

(5,344

)

Cash flows from financing activities:

Dividends paid

(6,528

)

(6,117

)

Purchases of treasury stock

-

(3,865

)

Tax adjustment related to restricted stock

-

(168

)

Net cash used in financing activities

(6,528

)

(10,150

)

Net increase in cash and cash equivalents

17,758

240

Cash and cash equivalents, at beginning of period

18,155

46,801

Cash and cash equivalents, at end of period

$

35,913

$

47,041

Supplemental disclosure of cash flow information:

Cash paid for income taxes

$

5,688

$

4,872

Dividends payable in accrued expenses

$

196

$

136